direct vivo rnai screen unveils myosin iia tumor suppressor squamous cell carcinomas
mining modern genomics cancer therapies predicated weeding bystander alterations nonconsequential mutations identifying driver mutations responsible tumorigenesis and/or metastasis used direct vivo rna interference rnai strategy screen genes upon repression predispose mice squamous cell carcinomas sccs seven top hits-including myh9 encodes nonmuscle myosin iia-have linked tumor development yet tissue-specific myh9 rnai myh9 knockout trigger invasive scc formation tumor-susceptible backgrounds human mouse keratinocytes myosin iias function manifested conventional actin-related processes also regulating posttranscriptional p53 stabilization myosin iia diminished human sccs poor survival suggests vivo rnai technology might useful identifying potent low-penetrance tumor suppressors
